LabConnect Commits to Science-Based Targets Initiative for Near-Term and Net-Zero Emissions Reduction

January 16, 2025, JOHNSON CITY, TN – LabConnect is proud to announce its commitment to the Science Based Targets initiative (SBTi). This commitment includes setting near-term science-based targets to reduce value chain emissions in line with limiting global temperature rise to 1.5°C, as well as setting long-term net-zero targets by 2050 or earlier.

LabConnect’s mission to create healthier communities by accelerating the development of new medicines remains steadfast. This new company-wide commitment to sustainability reinforces LabConnect’s dedication to addressing the environmental challenges facing the healthcare and clinical research sectors. By integrating sustainability into its operations and strategies, LabConnect aims to drive meaningful change while continuing to support its partners’ vital work.

“As a trusted partner in clinical research trials, LabConnect recognizes the urgent need for climate action and the role our industry must play in driving systemic change,” said Wes Wheeler, CEO of LabConnect. “By committing to SBTi, we are taking a significant step towards ensuring our operations and value chain are aligned with the latest climate science.”

To support this effort, LabConnect is pleased to welcome Benjamin Worley as Senior Director, Sustainability and ESG. Ben brings over a decade of experience leading sustainability initiatives, having previously served as an industry thought leader, author, and speaker in the field. His tenure at Spiro Carbon, a climate-tech company, showcased his ability to blend innovative strategies with impactful results, including spearheading programs that successfully reduced carbon emissions and promoted environmental stewardship across global operations.

“I am honored to join LabConnect at such a pivotal moment,” said Worley. “This commitment to SBTi demonstrates our resolve to lead by example, ensuring we make measurable progress toward reducing our environmental footprint while continuing to empower our partners to develop life-saving treatments.”

LabConnect’s SBTi commitment reflects its broader sustainability strategy, aimed at integrating environmental, social, and governance (ESG) principles across its global operations. The company will focus on reducing emissions across its value chain, enhancing resource efficiency, and engaging stakeholders to foster collective action.

By aligning with the SBTi’s rigorous standards, LabConnect joins a growing network of organizations worldwide taking decisive action to combat climate change. Together, these efforts reinforce the global imperative to cut emissions by half by 2030 and achieve net-zero before 2050.

For more information about LabConnect’s sustainability initiatives, visit https://www.labconnect.com/esg/.

About LabConnect

LabConnect is the leading provider of Central Laboratory Services, FSP and Scientific Consulting, and Data Integration and Transformation Services for analytically and logistically complex studies such as immuno-oncology, cell and gene therapies, and rare & orphan diseases. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to major and emerging markets, and extensive specialized testing expertise means that drug development companies can rely on one provider for all their central laboratory service needs. Learn more at labconnect.com and follow on LinkedIn.